Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections - Seite 3

Sonoma Pharmaceuticals, Microcyn and Microdox are trademarks or registered trademarks of Sonoma Pharmaceuticals, Inc. All other trademarks and service marks are the property of their respective owners.

[1] Singh G‐K, Deshpande A, Schlegel G, Starkey M, Taghavi K. The rationale for bladder washouts in children with neurogenic bladder. Neurourol Urodyn. 2024;1‐6. doi:10.1002/nau.25450

SOURCE: Sonoma Pharmaceuticals, Inc.

View the original press release on accesswire.com


The Sonoma Pharmaceuticals Stock at the time of publication of the news with a raise of +4,03 % to 0,150EUR on Tradegate stock exchange (04. April 2024, 10:01 Uhr).